These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 35032316

  • 1. Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model.
    Singh A, Rawat P, Choudhury D, Dixit A.
    Immunol Res; 2022 Apr; 70(2):240-255. PubMed ID: 35032316
    [Abstract] [Full Text] [Related]

  • 2. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis.
    Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F, Ducatelle R, Deprez P, Van Immerseel F.
    Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219
    [Abstract] [Full Text] [Related]

  • 3. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, Rodrigo-Mocholí D, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F.
    BMC Vet Res; 2016 Jun 13; 12(1):101. PubMed ID: 27297520
    [Abstract] [Full Text] [Related]

  • 4. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK, Melville SB.
    Infect Immun; 2004 Sep 13; 72(9):5204-15. PubMed ID: 15322015
    [Abstract] [Full Text] [Related]

  • 5. Perfringolysin O: The Underrated Clostridium perfringens Toxin?
    Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F, Ducatelle R, Deprez P, Wade KR, Tweten R, Van Immerseel F.
    Toxins (Basel); 2015 May 14; 7(5):1702-21. PubMed ID: 26008232
    [Abstract] [Full Text] [Related]

  • 6. The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells.
    Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Vermeulen K, Schauvliege S, Haesebrouck F, Ducatelle R, Deprez P, Van Immerseel F.
    Vet Res; 2013 Jun 19; 44(1):45. PubMed ID: 23782465
    [Abstract] [Full Text] [Related]

  • 7. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
    Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, Rodrigo-Mocholí D, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F.
    Vet Res; 2016 Apr 27; 47(1):52. PubMed ID: 27121298
    [Abstract] [Full Text] [Related]

  • 8. Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.
    Tweten RK.
    Infect Immun; 1988 Dec 27; 56(12):3228-34. PubMed ID: 2903127
    [Abstract] [Full Text] [Related]

  • 9. Phospholipid hydrolysis caused by Clostridium perfringens α-toxin facilitates the targeting of perfringolysin O to membrane bilayers.
    Moe PC, Heuck AP.
    Biochemistry; 2010 Nov 09; 49(44):9498-507. PubMed ID: 20886855
    [Abstract] [Full Text] [Related]

  • 10. The presence of differentiated C2C12 muscle cells enhances toxin production and growth by Clostridium perfringens type A strain ATCC3624.
    Li J, Sayeed S, McClane BA.
    Virulence; 2024 Dec 09; 15(1):2388219. PubMed ID: 39192628
    [Abstract] [Full Text] [Related]

  • 11. Piceatannol Alleviates Clostridium perfringens Virulence by Inhibiting Perfringolysin O.
    Wang G, Liu H, Gao Y, Niu X, Deng X, Wang J, Feng H, Guo Z, Qiu J.
    Molecules; 2022 Aug 12; 27(16):. PubMed ID: 36014383
    [Abstract] [Full Text] [Related]

  • 12. Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.
    Forti K, Cagiola M, Pellegrini M, Anzalone L, Di Paolo A, Corneli S, Severi G, De Giuseppe A.
    BMC Biotechnol; 2020 Jan 28; 20(1):7. PubMed ID: 31992276
    [Abstract] [Full Text] [Related]

  • 13. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J, Deng G, Wang J, Zhou J, Liu X, Xie Q, Wang Y.
    Vaccine; 2011 Jul 26; 29(33):5459-66. PubMed ID: 21641956
    [Abstract] [Full Text] [Related]

  • 14. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai J.
    Microbiol Immunol; 2013 May 26; 57(5):340-5. PubMed ID: 23668605
    [Abstract] [Full Text] [Related]

  • 15. The Barrier Disruption and Pyroptosis of Intestinal Epithelial Cells Caused by Perfringolysin O (PFO) from Clostridium perfringens.
    Liu Z, Mou S, Li L, Chen Q, Yang R, Guo S, Jin Y, Liu L, Li T, Chen H, Wang X.
    Cells; 2024 Jul 03; 13(13):. PubMed ID: 38994991
    [Abstract] [Full Text] [Related]

  • 16. Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum.
    Hickey MJ, Kwan RY, Awad MM, Kennedy CL, Young LF, Hall P, Cordner LM, Lyras D, Emmins JJ, Rood JI.
    PLoS Pathog; 2008 Apr 11; 4(4):e1000045. PubMed ID: 18404211
    [Abstract] [Full Text] [Related]

  • 17. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.
    Rafii F, Park M, Bryant AE, Johnson SJ, Wagner RD.
    Antimicrob Agents Chemother; 2008 Mar 11; 52(3):895-900. PubMed ID: 18160514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.